AKT1 and breast carcinoma: Perifosine, MK-2206, RX-0201, PBI-05204 and GSK2141795 are some of the potential AKT inhibitors being investigated in several cancers [50].The role of AKT in promoting cell proliferation and survival in hormone responsive MCF-7 breast cancer cells has been previously studied [51].